Insulet recently announced that its Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System, enhancing its Automated Insulin Delivery capabilities. Over the ...
Insulet (NASDAQ:PODD) has received FDA clearance for an iPhone app for its Omnipod 5 insulin delivery system. The company said the approval makes Insulet the first company to offer a tubeless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback